Form 4: VYNE Therapeutics Executive Mutya Harsch Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Mutya Harsch, Chief Legal Officer and GC of VYNE Therapeutics, disposed of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 31, 2025, Mutya Harsch, the Chief Legal Officer and GC of VYNE Therapeutics Inc., disposed of 8,828 shares of common stock.
- The disposal was executed to satisfy tax withholding requirements related to the vesting of restricted stock units.
- Following the transaction, Harsch directly owns 135,501 shares of VYNE Therapeutics Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations, not indicative of a change in the executive's confidence in the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock. This filing indicates a routine transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of transaction: disposal of shares for tax withholding. |
| 04/02/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, VYNE Therapeutics, Mutya Harsch, Stock Disposal, Tax Withholding, Restricted Stock Units, Beneficial Ownership, Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.